Keun Wha Pharmaceutical Co., Ltd.

Beginning with the foundation as a pharmaceutical manufacturer focused on antibiotics in 1958, Keun Wha Pharmaceutical has produced the Korea's first tetracycline and streptomycin and, thanks to your patronage and support, has now become a leading company playing a key role in the pharmaceutical industry.

Keun Wha Pharmaceutical's entire staf
f endeavour to contribute to improve human health and the quality of society by supplying superior drugs based on the experience and technology gained since its establishment in 1958, we have also produced over 100 pharmaceutical products, especially Somalgen tablet and Cerebrolysin injection, in collaboration with worldwide pharmaceutical companies and with the quality control under GMP(Good Manufacturing Practices) facilities in Kong Ju plant.

The world is fast-becoming a single market and th
e marketing boundaries between nations hqve already disappeared. To cope with this changing environment, we have set as our objectives to overcome incurable diseases such as diabetes, cancer, dementia, hypertension by development of value-added new drug using the advanced technology including genetic engineering, etc. Together, we will also improve services to provide satisfaction to customers, enhancing marketing competitiveness by streamlining management.

Keun Wha Pharmaceutical will continue
to repay your patronage and support by redoubling our every effort and also dedicate ourselves to the missions of leading the pharmaceutical industry in the approaching 21st century.
Thank you.